FDA Inspection
Corixa CorporationCorixa Corporation – FDA Inspection, May 16, 2017
Record Details
This FDA Inspection record concerns Corixa Corporation, with an inspection on May 16, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · c2db1e9f-95ba-4300-8f45-160737c1037a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1016267
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
- Outcome
- Form 483 issued
Other FDA inspections of Corixa Corporation
4| Date | Classification | Office | Project area |
|---|---|---|---|
| March 12, 2026 | Not classified | Philadelphia District Office | Vaccine, Allergenic, and Live Biotherapeutic Products |
| February 9, 2024 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| April 15, 2019 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| May 13, 2015 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
Other documents for Corixa Corporation
- FDA Inspection 1298224 - 2026-03-12
- FDA Inspection 1229084 - 2024-02-09
- FDA Inspection 1091132 - 2019-04-15
- FDA Inspection 938930 - 2015-05-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.